leadf
logo-loader
NASDAQ:CYCC

Cyclacel Pharmaceuticals Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$20.28 m
Price
4.17 USD
Change
0.24%
52 weeks high
19.58
52 weeks low
3.13

In brief

Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company developing innovative therapies that target various phases of cell cycle control for the treatment of cancer and other serious diseases.